革新的がん研究支援室

AMED news

AMED news - Detail

2018.12.18
Loss of KDM6A characterizes a poor prognostic subtype of human pancreatic cancer and potentiates HDAC inhibitor lethality
A press release from the Japan Agency for Medical Research and Development (AMED):

Loss of KDM6A characterizes a poor prognostic subtype of human pancreatic cancer and potentiates HDAC inhibitor lethality

Visit AMED website